Concepedia

Author

Elisabet García

European Foundation for the Study of Chronic Liver FailureORCID

Also Known As

E García, E. Garcia, E. Garcia-Lopez, E. García, E. García García, E. García-López, Eduardo Miñambres Garcia, Elisabet Garcia, Elisabet Garcia-Lopez, Elisabet García

34

Publications

3.4K

Citations

17

H-Index

35

Concepts

All Affiliations

European Foundation for the Study of Chronic Liver FailureUniversity of PaduaHospital Clínic de BarcelonaUniversitat de BarcelonaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
EG

About

Elisabet García is an author at European Foundation for the Study of Chronic Liver Failure specializing in medicine, hepatology, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

1.5K

2

Hepatology

7

7

1.5K

3

Emergency Medicine

3

3

506

4

Gastroenterology

2

2

132

5

Health Sciences

1

1

354

Elisabet García

×

18

Publications

3.4K

Citations

17

H-Index

YearCitations

Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

Thierry Gustot, Javier Fernández, Elisabet García,

Hepatology

2015

612

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Jonel Trebicka, Javier Fernández, Mária Papp,

Journal of Hepatology

2020

478

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe

Javier Fernández, Verónica Prado, Jonel Trebicka,

Journal of Hepatology

2018

354

A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis

Cláudia Fagundes, Rogelio Barreto, Mónica Guevara,

Journal of Hepatology

2013

308

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Jonel Trebicka, Javier Fernández, Mária Papp,

Journal of Hepatology

2020

276

Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis

Cláudia Fagundes, Marie-Noëlle Pépin, Mónica Guevara,

Journal of Hepatology

2012

232

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

Jonel Trebicka, Luis Ibáñez, Virginia Hernández–Gea,

Journal of Hepatology

2020

181

Acute Kidney Injury Is an Early Predictor of Mortality for Patients With Alcoholic Hepatitis

José Altamirano, Cláudia Fagundes, Marlene Domínguez,

Clinical Gastroenterology and Hepatology

2011

180

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

Xavier Ariza, Isabel Graupera, Mar Coll,

Journal of Hepatology

2016

138

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)

Henning Grønbæk, Sidsel Rødgaard‐Hansen, Niels Kristian Aagaard,

Journal of Hepatology

2015

132

Page 1